Latest Cancer Imaging News

Page 5 of 5

Clarity Pharmaceuticals Accelerates Prostate Cancer Imaging with FDA Fast Track Nod

Clarity Pharmaceuticals has secured a second FDA Fast Track Designation for its 64Cu-SAR-bisPSMA diagnostic agent, aiming to revolutionize prostate cancer imaging and speed regulatory approval.

Ada Torres

24 Jan 2025

Top